Original articleSustained Delivery Fluocinolone Acetonide Vitreous Implants: Long-Term Benefit in Patients with Chronic Diabetic Macular Edema
Abbreviations and Acronyms
Cited by (0)
∗Supplemental material is available at www.aaojournal.org.
Financial Disclosure(s): The author(s) have made the following disclosure(s):
José Cunha-Vaz: Consultant and Study investigator – Alimera Sciences, Bayer, Fovea Pharmaceuticals, Gene Signal, Novartis, OM Pharma, Pfizer, Roche, ThromboGenics, Zeiss
Paul Ashton: Employee – Alimera Sciences; Patent – Alimera Sciences; Royalties – pSivida
Raymond Iezzi: Advisory Board, Equity owner, Financial support – Alimera Sciences; Patent – Dendrimers for Sustained Release of Compounds
Peter Campochiaro: Financial support – Alimera Sciences, Allergan, Aerpio Therapeutics, Genzyme, GlaxoSmithKline, Oxford Biomedica, Genentech; Consultant – Advanced Cell Technology, Aerpio Therapeutics (paid to institution), Applied Genetic Technologies, Gene Signal, Regeneron (paid to institution), Genentech (paid to institution)
Frank G. Holz: Financial support (paid to institution) – Alimera Sciences, Novartis, Bayer Healthcare, GSK, Alcon, Optos, Heidelberg Engineering, Carl Zeiss Meditec; Consultant – Alimera Sciences; Bayer Healthcare, Heidelberg Engineering, Novartis, Pfizer, Acucela, Genentech, Alcon, Allergan; Financial support (for travel) – Alimera Sciences; Lecturer – Alcon, Pfizer, Novartis, Heidelberg Engineering, Bayer Healthcare
Ronald P. Danis: Financial support (paid to institution) – Alimera Sciences
Baruch D. Kuppermann: Investigator and Consultant – Alimera Sciences, Allergan, Genentech, GSK, Pfizer, Regeneron, ThromboGenics; Consultant – Alcon, Allegro, Ampio, Glaukos, Neurotech, Novagali, Novartis, Ophthitech, Santen, SecondSight, Teva
Kathleen Billman: Financial support (for travel), Employee, Equity owner – Alimera Sciences
Barry Kapik: Financial support (for travel), Employee, Equity owner – Alimera Sciences
Frances Kane: Financial support (for travel), Employee, Equity owner – Alimera Sciences
Ken Green: Financial support (for travel), Employee, Equity owner – Alimera Sciences
Supported by Alimera Sciences, Inc, Alpharetta, Georgia. The sponsor participated in the design of the study, conducting the study, data collection, data management, data analysis, interpretation of the data, preparation of the manuscript, and review of the manuscript.
- ∗
Members of the FAME Study Group are listed in Campochiaro PA, Brown DM, Pearson A, et al. Ophthalmology 2011;118:626–35.e2.